Risk of quality defects, recalls and deterioration in brand reputation
First written in FY2016. 5 of 8 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2025: 10 of 30 companies on the "Worse" side.
18 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「The Group is working to establish an operating framework to address the European Cyber Resilience Act (CRA), which will be partially applicable from September 2026.」
As a response to quality defect and recall risks, establishing an operating framework for the European Cyber Resilience Act has been added to the existing measures involving IC analysis and software vulnerabilities. - FY2025RestatedAnnual report
「As the number of products incorporating ICs and software is increasing, the Group is also working to strengthen its IC analysis technology and measures against software vulnerabilities.」
IC analysis and measures against software vulnerabilities as responses to quality defect and recall risks continue. - FY2024RestatedAnnual report
「As the number of products incorporating ICs and software is increasing, the Group is also working to strengthen its IC analysis technology and measures against software vulnerabilities.」
As responses to quality defect and recall risks, efforts to strengthen IC analysis and measures against software vulnerabilities continue. - FY2021MitigatedAnnual report
「As the number of products incorporating ICs and software is increasing, the Group is also working to strengthen its IC analysis technology and measures against software vulnerabilities.」
The response to quality defect and recall risks has been made more specific to include IC analysis and measures against software vulnerabilities. - FY2020RestatedAnnual report
「However, quality defects, including the presence of regulated substances, and recalls resulting from them may occur.」
The residual risks of quality defects, recalls and deterioration in brand reputation have been reconfirmed. - FY2019RestatedAnnual report
「However, quality defects, including the presence of regulated substances, and recalls resulting from them may occur.」
The residual risks of quality defects, recalls and deterioration in brand reputation have been reconfirmed. - FY2018RestatedAnnual report
「However, unforeseeable quality defects, including the presence of regulated substances, and recalls resulting from them may occur.」
The residual risks of quality defects, recalls and deterioration in brand reputation continue to be disclosed together with an explanation of the quality assurance system. - FY2016First statedAnnual report
「However, unforeseeable quality defects, including the presence of regulated substances, and recalls resulting from them may occur.」
After describing its quality assurance system, including ISO 9001, design reviews, audits and process control, the Group identifies the residual risks.